Cyanotech is a manufacturing company in the medicinal and botanical space that focuses on microalgae-based, high-value nutrition and health dietary supplement products. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets.
Cyborg Score Rationale
With a stock price of $0.3891 (as of April 2026) and market cap of approximately $2.4M, Cyanotech faces significant capitalization constraints. The company posted trailing twelve months revenue of $24.2M but net income of -$3.2M, indicating operational challenges despite meaningful sales. Proprietary microalgae technology and established brands provide differentiation, but scale and profitability concerns persist.
Top Insights
Unique competitive advantage: 96-acre dedicated microalgae production facility in Hawaii using patented proprietary technology
Profitability gap: Company recorded net income loss of -$3.2M and operating loss of -$2.5M in trailing twelve months
Two flagship brands with proven market acceptance: BioAstin Hawaiian Astaxanthin (antioxidant for skin, eye, joint health) and Hawaiian Spirulina Pacifica (nutrient-rich supplement)
Established company: Cyanotech was incorporated in 1983 with 40+ years of operational history and market presence
Named Competitors
Oragin Foods — Nutraceutical company in packaged foods sector
Glucose Health — Health supplement manufacturer
The Planting Hope Company — Plant-based nutrition company
Recent Developments
(November 2025) Q2 2026 earnings call held on November 11, 2025
(April 2026) Stock trading at $0.3891 with market cap of $2.4M
Open the full interactive Cyanotech Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.